Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CNS Pharmaceuticals (CNSP)
NASDAQ:CNSP
CNS Pharmaceuticals (CNSP) Stock Price & Analysis
823 Followers
CNSP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.24 - $137.50
Previous Close$1.26
Volume54.58M
Average Volume (3M)421.81K
Market Cap
$330.67K
Enterprise Value$50.75K
Total Cash (Recent Filing)$548.72K
Total Debt (Recent Filing)$300.81K
Price to Earnings (P/E)―
Beta0.49
Next Earnings
Aug 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-174.04
Shares Outstanding237,039
10 Day Avg. Volume1,183,856
30 Day Avg. Volume421,808
Standard Deviation0.27
R-Squared0.06
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)-0.11
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CNS Pharmaceuticals News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CNSP FAQ
What was CNS Pharmaceuticals’s price range in the past 12 months?
CNS Pharmaceuticals lowest stock price was $1.24 and its highest was $137.50 in the past 12 months.
What is CNS Pharmaceuticals’s market cap?
Currently, no data Available
When is CNS Pharmaceuticals’s upcoming earnings report date?
CNS Pharmaceuticals’s upcoming earnings report date is Aug 12, 2024 which is in 40 days.
How were CNS Pharmaceuticals’s earnings last quarter?
CNS Pharmaceuticals released its earnings results on May 16, 2024. The company reported -$0.407 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.407.
Is CNS Pharmaceuticals overvalued?
According to Wall Street analysts CNS Pharmaceuticals’s price is currently Overvalued.
Does CNS Pharmaceuticals pay dividends?
CNS Pharmaceuticals does not currently pay dividends.
What is CNS Pharmaceuticals’s EPS estimate?
CNS Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CNS Pharmaceuticals have?
CNS Pharmaceuticals has 237,039 shares outstanding.
What happened to CNS Pharmaceuticals’s price movement after its last earnings report?
CNS Pharmaceuticals reported an EPS of -$0.407 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 12.625%.
Which hedge fund is a major shareholder of CNS Pharmaceuticals?
Currently, no hedge funds are holding shares in CNSP
---
CNS Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-98.86%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-77.60%
Trailing 12-Months
Company Description
CNS Pharmaceuticals
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
---
CNSP Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---